Spectrum Pharmaceuticals Named One of the Best Places to Work in Orange County

Spectrum Pharmaceuticals Named One of the Best Places to Work in Orange County

Spectrum Pharmaceuticals, Inc.Shiv Kapoor, 702-835-6300Vice President, Strategic Planning & Investor Relations

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced it was named one of the Best Places to Work in Orange County by the and Best Companies Group.

The awards program was designed to identify, recognize and honor the best employers in Orange County, benefiting the county's economy, workforce and businesses. Companies from across the county were assessed based on company size (small, medium or large). Spectrum has been named one of this year’s Best Places to Work in Orange County in the medium category (50-249 U.S. employees).

The survey process included the evaluation of a company's workplace policies, practices, philosophy, systems and demographics. The second part consisted of an employee survey to measure employees’ satisfaction. The combined scores determined the top companies and the final rankings.

Best Companies Group managed the survey process in Orange County, analyzed the data and determined the final rankings. The actual rankings will be published in the special report on the Best Places to Work in the October 29, 2012 issue of the .

“This is Spectrum’s third time being named one of the ’Best Places to Work’ and it is a continued source of pride for the Company. Our team has expertise and passion in the business and every employee brings a unique skill and voice that is critical to the success of our Company,” stated Rajesh C. Shrotriya, M.D., Chairman, President and Chief Executive Officer of Spectrum Pharmaceuticals, Inc. “With a dedicated and passionate team, we are able to accomplish our goals effectively and in the best interest of cancer patients. It is an honor to work alongside such motivated and committed people for a cause we all deeply believe in, to provide most optimal treatment options for people suffering from cancer.”

Spectrum Pharmaceuticals maintains a research and development facility in Irvine, CA, with headquarters in Henderson, Nevada.

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in oncology and hematology. Spectrum currently markets two oncology drugs ─ FUSILEV® (levoleucovorin) for Injection in the U.S. and ZEVALIN® (ibritumomab tiuxetan) Injection for intravenous use, for which the Company has worldwide marketing rights. Spectrum's strong track record in in-licensing and acquiring differentiated drugs, and expertise in clinical development have generated a robust, diversified, and growing pipeline of product candidates in advanced-stage Phase 2 and Phase 3 studies. More information on Spectrum is available at .

Suggested Articles

Cancer biotech Zentalis Pharmaceuticals priced its IPO at $165 million, eclipsing the $100 million goal it laid out in early March.

The agreement gives Innovax access to a GSK adjuvant to enhance the immune response triggered by its recombinant protein-based vaccine.

Johnson & Johnson is paying Fate Therapeutics $50 million upfront to collaborate on up to four CAR NK and CAR-T cell therapies.